findmyKOL

Ibrahim Abdulhamid, MD

Basic profile

College for Creative Studies

ORCIDNone on fileNPI
RegionDetroit, MI · MidwestSpecialtyPediatric PulmonologyFocusRespiratory
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ibrahim Abdulhamid is a Respiratory physician affiliated with College for Creative Studies. OpenAlex indexes 83 publications with 1,485 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
83publications

Distinct works indexed by OpenAlex.

1,485citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3901 Beaubien
2nd Floor Carl'S Building
Detroit, MI 48201

Telephone

313-745-5541

Registry record last updated 23 Nov 2015.

View the NPPES registry record

Industry payments

7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    41.9%
    Antidiarrheal microorganisms41.9%
    Creon100%
    Part D<11 patients
  • Respiratory

    32.6%
    Other respiratory system products32.6%
    Trikafta100%
    Part D<11 patients
  • Anti-infectives

    25.6%
    Macrolide Antimicrobial25.6%
    Azithromycin100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”